Publications by authors named "Cheng-Bin Dong"
Background: Gut microbiota (GM) affects the progression and response to treatment in liver diseases. The GM composition is diverse and associated with different etiologies of liver diseases. Notably, alterations in GM alterations are observed in patients with portal hypertension (PH) secondary to cirrhosis, with hepatitis B virus (HBV) infection being a major cause of cirrhosis in China.
View Article and Find Full Text PDFArticle Synopsis
- Doctors studied how to predict long-term survival for patients with liver problems after a procedure called TIPS, which helps with high blood pressure in the liver.
- They looked at 224 patients and found some important factors that help determine survival, like how serious the liver was, blood pressure changes, and liver function tests.
- A new model called the NDC was created using these factors, and it works better than older models to identify which patients might have higher risks after the procedure.
Article Synopsis
- Scientists are creating a tool called a nomogram to help predict if patients will have brain problems after a specific liver treatment.
- They studied 296 patients who had this treatment and found important health factors like age and blood tests that could indicate risk.
- The new tool is better at predicting problems than older methods, making it a helpful way for doctors to assess patient risks.
Background: The liver is one of the most important organs in the human body, with functions such as detoxification, digestion, and blood coagulation. In terms of vascular anatomy, the liver is divided into the left and the right liver by the main portal vein, and there are three hepatic efferent veins (right, middle, and left) and two portal branches. Patients with impaired liver function have increased intrahepatic vascular resistance and splanchnic vasodilation, which may lead to an increase in the portal pressure gradient (PPG) and cause portal hypertension (PHT).
View Article and Find Full Text PDF